Delivery Order SPE2DB22D3011-SPE2DB24FQ0CE
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CEFDINIR 125 MG/5 ML SUSP 60ML. The contract has a ceiling value of $16,155.67 and an ultimate completion date of March 19, 2025. It is a firm fixed-price contract and was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CEFDINIR 250MG/5ML 1S, a pharmaceutical product. The contract has a ceiling value of $1,336.41 and is a firm fixed-price delivery order with a completion date of May 15, 2025. The contract is not set aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $1,633.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CEFDINIR 300 MG CAPSULE 60S, a pharmaceutical product, with a performance period through May 13, 2025. This delivery order is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,732.47, is a delivery order for the pharmaceutical product CEFDINIR 250 MG/5 ML SUSP 60ML. The contract has an ultimate completion date of November 18, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of CEFDINIR 250 MG/5 ML SUSP 100ML. The contract has a ceiling value of $1,373.23 and is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of September 20, 2023. This contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,994.30 with a completion date of October 27, 2023. It is for the provision of 4562613708 CEFDINIR 300 MG CAPSULE 60S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition....
- This federal contract award, with a ceiling value of $4,086.28, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of CEFDINIR 250 MG/5 ML SUSP 60ML, a pharmaceutical product, with an ultimate completion date of April 12, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation indicated. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,913.72 firm fixed price delivery order is for the supply of 4567253160 - CEFDINIR 300 MG CAPSULE 60S, with a completion date of February 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 300 mg Cefdinir capsules, with a ceiling value of $1,062.45 and a completion date of July 17, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific program or business type. AmerisourceBergen Drug Corp holds a substantial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) with a contract ceiling value of $1,774.40. This firm fixed price delivery order, with an ultimate completion date of September 2, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FQ0CEDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical distributor, to provide CEFDINIR 125 MG/5 ML SUSP 100ML, a specialty pharmaceutical product, in support of military treatment programs and facilities. The order, valued at $3,274.91, has an ultimate completion date of March 26, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 3/25/24 |